Identification of a novel Shank2 transcriptional variant in Shank2 knockout mouse model of autism spectrum disorder
MOLECULAR BRAIN
Authors: Lee, Yong-Seok; Yu, Nam-Kyung; Chun, Jeewan; Yang, Jung-Eun; Lim, Chae-Seok; Kim, Hyopil; Park, Gaeun; Lee, Jin-A; Lee, Kyungmin; Kaang, Bong-Kiun; Lee, Jae-Hyung
Abstract
Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders that are highly heterogeneous in clinical symptoms as well as etiologies. Mutations in SHANK2 are associated with ASD and accordingly, Shank2 knockout mouse shows ASD-like behavioral phenotypes, including social deficits. Intriguingly, two lines of Shank2 knockout (KO) mouse generated by deleting different exons (exon 6-7 or exon 7) showed distinct cellular phenotypes. Previously, we compared gene expressions between Shank2 KOs lacking exon 6-7 (e6-7 KO) and KOs lacking exon 7 (e7 KO) by performing RNA-seq. In this study, we expanded transcriptomic analyses to identify novel transcriptional variants in the KO mice. We found prominent expression of a novel exon (exon 4 ' or e4') between the existing exons 4 and 5 in the Shank2 e6-7 KO model. Expression of the transcriptional variant harboring this novel exon was confirmed by RT-PCR and western blotting. These findings suggest that the novel variant may function as a modifier gene, which contributes to the differences between the two Shank2 mutant lines. Furthermore, our result further represents an example of genetic compensation that may lead to phenotypic heterogeneity among ASD patients with mutations in the same gene.
Differential expression and dendritic transcript localization of Shank family members: identification of a dendritic targeting element in the 3 ' untranslated region of Shank1 mRNA
MOLECULAR AND CELLULAR NEUROSCIENCE
Authors: Bockers, TM; Segger-Junius, M; Iglauer, P; Bockmann, J; Gundelfinger, ED; Kreutz, MR; Richter, D; Kindler, S; Kreienkamp, HJ
Abstract
Shank proteins are scaffolding proteins in the postsynaptic density of excitatory synapses in the mammalian brain. In situ hybridization revealed that Shank1/SSTRIP and Shank2/ProSAP1 mRNAs are widely expressed early in postnatal brain development whereas Shank3/ProSAP2 expression increases during postnatal development especially in the cerebellum and thalamus. Shank1 and Shank3 (but not Shank2) mRNAs are present in the molecular layers of the hippocampus, consistent with a dendritic transcript localization. Shank1 and Shank2 transcripts are detectable in the dendritic fields of Purkinje cells, whereas Shank3 mRNA is restricted to cerebellar granule cells. The appearance of dendritic Shank mRNAs in cerebellar Purkinje cells coincides with the onset of dendrite formation. Expression of reporter transcripts in hippocampal neurons identifies a 200-nucleotide dendritic targeting element (DTE) in the Shank1 mRNA. The widespread presence of Shank mRNAs in dendrites suggests a role for local synthesis of Shanks in response to stimuli that induce alterations in synaptic morphology. (C) 2004 Elsevier Inc. All rights reserved.